Sanjeev Pathak, MD is Fellow, VP, Clinical Development Neurology & Psychiatry at Alkermes, Inc.
He is a drug developer, clinical researcher and clinical physician with over 20 years of experience across the pharmaceutical industry and academia. He served previously in various leadership positions at AstraZeneca. Before joining AstraZeneca, Sanjeev was an Assistant Professor of Psychiatry and Pediatrics at University of Cincinnati, College of Medicine, Cincinnati Children’s Hospital Medical Center. He holds an M.D. and is board certified in Psychiatry as well as Child and Adolescent Psychiatry (American Board of Psychiatry and Neurology). He has led global drug development teams from Phase I-IV, across multiple disease states in Neurology and Psychiatry. The disease states include autism, fragile X syndrome, Alzheimer’s disease, migraine, opioid induced constipation, schizophrenia, bipolar disorder etc. He has also led and supported filing of several New Drug Applications (NDAs) or supplemental NDAs.